A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
e130 13th International Congress on Infectious Diseases Abstracts, Poster Presentations Brucellosis and confirm the diagnostic problems of S19 vaccination. According to the passages, and the other investigators' findings, we can declare that the new vaccine (RB51) is potentially suitable for being used in the control and prevention program of bovine Brucellosis and its usage has been satisfactory in Iran over these years and is a successful replacement for S19 vaccine.doi:10.1016/j.ijid.2008.05.324 fatcat:n7arorapkvenrclqzp3xfgx5ze